Nautilus Biotechnology, Inc.·4

Sep 5, 6:34 PM ET

Murphy Matthew B. 4

4 · Nautilus Biotechnology, Inc. · Filed Sep 5, 2025

Insider Transaction Report

Form 4
Period: 2025-09-04
Murphy Matthew B.
General Counsel
Transactions
  • Purchase

    Common Stock

    2025-09-04$0.64/sh+20,000$12,85874,140 total(indirect: See Footnote)
Holdings
  • Common Stock

    1,250
Footnotes (1)
  • [F1]Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.

Documents

1 file
  • 4
    wk-form4_1757111657.xmlPrimary

    FORM 4